Table 2.
Characteristics of the study participants.
| Characteristics | Value (percentages) | p -value |
|---|---|---|
| Gender | ||
| Male | 17 (41.5%) | |
| Female | 24 (58.5%) | |
| MG type according to age at onset | ||
| EOMG | 28 (68.3%) | |
| LOMG | 13 (31.7%) | |
| MG type according to clinical manifestations | ||
| OMG | 23 (56.1%) | |
| GMG | 18 (43.9%) | |
| Anti-AChR antibody | ||
| Seropositive | 34 (82.9%) | |
| Seronegative | 7 (17.1%) | |
| Thymic abnormality* | ||
| Normal | 26 (72.2%) | |
| Thymic hyperplasia | 6 (16.7%) | |
| Thymoma | 4 (11.1%) | |
*
The frequencies of thymic abnormalities from 36 MG patients which are collected in Table 1.
These did not include all the specimens used in the thymus experiment (Alteration of CD19 + IL-10 + B Cells in the Thymus of MG Patients).